ENTA(Enanta Pharmaceuticals, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2025-12-05 | Capps Kathleen S. | See Remarks | 公开市场卖出 | 323 | $14.23 |
| 2025-12-05 | Trout Harry R. III | See Remarks | 公开市场卖出 | 542 | $14.23 |
| 2025-12-05 | Rottinghaus Scott T. | Chief Medical Officer | 公开市场卖出 | 798 | $14.23 |
| 2025-12-05 | Luu Brendan | Chief Business Officer | 公开市场卖出 | 1,394 | $14.23 |
| 2025-12-05 | Kieffer Tara Lynn | Chief Product Strategy Officer | 公开市场卖出 | 2,106 | $14.23 |
| 2025-12-05 | Or Yat Sun | Chief Scientific Officer | 公开市场卖出 | 2,390 | $14.23 |
| 2025-12-05 | Luly Jay R. | President and CEO | 公开市场卖出 | 4,743 | $14.23 |
| 2025-12-02 | Capps Kathleen S. | See Remarks | 公开市场卖出 | 207 | $13.96 |
| 2025-12-02 | Trout Harry R. III | See Remarks | 公开市场卖出 | 380 | $13.96 |
| 2025-02-12 | Luly Jay R. | President and CEO | 公开市场买入 | 45,000 | $5.69 |
| 2024-12-06 | Kieffer Tara Lynn | Chief Product Strategy Officer | 公开市场卖出 | 2,283 | $8.06 |
| 2024-12-06 | Luu Brendan | Chief Business Officer | 公开市场卖出 | 2,283 | $8.06 |
| 2024-12-06 | Rottinghaus Scott T. | Chief Medical Officer | 公开市场卖出 | 866 | $8.06 |
| 2024-12-06 | Or Yat Sun | Chief Scientific Officer | 公开市场卖出 | 2,591 | $8.06 |
| 2024-12-06 | MELLETT PAUL J | Chief Fin. & Admin Officer | 公开市场卖出 | 2,591 | $8.06 |
| 2024-12-06 | Luly Jay R. | President and CEO | 公开市场卖出 | 5,142 | $8.06 |